NCT00257530View on ClinicalTrials.gov

Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Cutaneous Leishmaniasis
Interventions
DRUG

Imiquimod

Trial Locations (2)

Unknown

UPCH, Cusco

IMT Alexander Von Humboldt, Lima

All Listed Sponsors
lead

Drugs for Neglected Diseases

OTHER

NCT00257530 - Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis | Biotech Hunter | Biotech Hunter